Navigation Links
AutoImmune Inc. Reports 2008 Third Quarter Financial Results
Date:11/7/2008

PASADENA, Calif., Nov. 7 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $23,000, or break even per share basic and diluted, for the three months ended September 30, 2008, compared with a net loss of $8,000, or break even per share basic and diluted, for the three months ended September 30, 2007. For the nine months ended September 30, 2008, the net loss was $216,000, or $0.01 per share basic and diluted, compared with net loss of $62,000, or break even per share basic and diluted for the same period in 2007. As of September 30, 2008, the Company reported $8.6 million in cash and marketable securities as compared to $8.8 million in cash and marketable securities as of December 31, 2007.

Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "Product sales at Colloral LLC during the third quarter were unchanged from the same period prior year." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with FIN 46 "Consolidation of Variable Interest Entities."

AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical Corp., a Canadian company. Under the license agreement, BioMS makes monthly diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug, MBP8298, if it reaches the market. In December 2007, BioMS sublicensed its rights in this product to Eli Lilly and Company. During the third quarter just completed, BioMS announced the product was granted fast track designation by the FDA and that it had received a milestone payment from Eli Lilly for successfully passing an interim analysis for safety and futility in its pivotal phase II/III trial of MBP8208 for treatment of secondary progressive multiple sclerosis. We expect the final trial data will be available during the second half of 2009.

AutoImmune is a biopharmaceutical company involved in the development of
'/>"/>

SOURCE AutoImmune Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
2. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
3. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
4. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
5. Dendreon Reports Third Quarter 2008 Financial Results
6. Osteotech Reports 2008 Third Quarter Financial Results
7. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
8. Oncothyreon reports third quarter 2008 financial results
9. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
10. NeurogesX Reports Third Quarter 2008 Results
11. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Research and Markets has announced the addition ... Report 2014" report to their offering. ... 2014 is a professional and in-depth study on the ... a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The microcrystalline ...
(Date:9/22/2014)... Sept. 22, 2014  Neogen Corporation (Nasdaq: ... first quarter of its 2015 fiscal year, which ended ... to net income of $7,839,000 in the first quarter ... effective Oct. 30, 2013, earnings per share in the ... ago. First quarter revenues increased 15% to ...
(Date:9/22/2014)... -- The US markets on Friday, September ... Dow Jones Industrial Average finished at 17,279.74, up 0.08% ... The S&P 500 finished the session 0.05% lower at ... sectors finished on a positive note. The S&P 500 ... up 0.10%, with the index gaining 6.95% in the ...
(Date:9/22/2014)... , Sept. 22, 2014  Spherix Incorporated (SPEX) -- ... monetization of intellectual property, today announced that the United States ... the Company in the month of September that is part ... The issued patent is: USRE45,121 , Application number: ... , Filing date: Dec 27, 2012 The ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3
... - Last Sunday morning, in the free-wheeling environment of ... secrets and strategies from her forthcoming book, titled ... expects to publish next year. , ,In her seminar ... provided advice about maximizing efficiency and minimizing hurt feelings ...
... Just one week ago, 67 companies were nervously introducing ... business development executives, early adopters, and eager media. , ... were nearly flawless. John Patrick's FutureScan panels were smart. ... the Wi-Fi was glitch-free. , ,The DEMOgods smiled ...
... Wis. - Wisconsin's role in tackling the world's most ... the 2006 annual conference of the Wisconsin Biotechnology and ... held Oct. 12 at the GE Healthcare Institute ... Jim Doyle and former Gov. Tommy Thompson, but session ...
Cached Biology Technology:BarCamp talk turns to Internet dating 2BarCamp talk turns to Internet dating 3Basking (briefly) in the DEMOfall 2006 glow 2Wisconsin's role in health a focus of biotech event 2Wisconsin's role in health a focus of biotech event 3
(Date:9/22/2014)... in Khabarovsk Krai, a territory occupying the coastline of the ... of smoke mark active fires. The smoke, which appears mostly ... of Okhotsk. Taiga and tundra are found in ... depression, and deciduous forests are the natural vegetation in the ... the summer, the 2014 wildfire season appears to be more ...
(Date:9/22/2014)... warming, larger and larger areas of sea ice melt in ... the winter it is thinner and more reduced. As the ... of global warming, because reduced sea ice in the Arctic ... , "If our results are representative, then sea ice plays ... into account in future global CO2 budgets", says Dorte Haubjerg ...
(Date:9/21/2014)... of cowpea (black-eyed peas) is a fascinating example of ... fascinating is the story of the scientist behind the ... Legume of the 21st Century to serve as an ... book was recently published by the Crop Science Society ... Agriculture (IITA). , Singh has devoted his life,s work ...
Breaking Biology News(10 mins):Arctic sea ice helps remove CO2 from the atmosphere 2
... WASHINGTON, April 25, 2012 Research!America President and CEO Mary ... Departments of Labor and Health and Human Services is far ... saves lives and spurs new businesses and jobs throughout the ... level that,s $19 billion below what was mandated under last ...
... the Broad Institute of MIT and Harvard have announced ... analysis tools, is now available to the scientific community. ... Expo on Tuesday, Jill Mesirov, director of computational biology ... and tool developers to explore this beta release of ...
... LONDON, ON Patients suffering with end-stage renal disease ... at home rather than the conventional dialysis in clinics. ... the potential of more intensive dialysis completed in a ... who underwent intensive dialysis at home have better survival ...
Cached Biology News:Researchers announce GenomeSpace environment to connect genomic tools 2Researchers announce GenomeSpace environment to connect genomic tools 3
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
Request Info...
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
Request Info...
Biology Products: